Seeking Alpha

Denali Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (DNLI) today reported financial results for the third quarter ended September 30, 2025, and provided business ...
Seeking Alpha

Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome

SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (DNLI) today reported financial results for the first quarter ended March 31, 2025, and provided business ...